Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of iShares Biotechnology ETF (NASDAQ:IBB) through any online brokerage.
There are no as such competitors for iShares Biotechnology ETF.
There is no analysis for iShares Biotechnology ETF to provide a consensus price target.
The stock price for iShares Biotechnology ETF (NASDAQ: IBB) is $206.85 last updated September 9, 2026 at 9:29 AM EDT.
There are no upcoming dividends for iShares Biotechnology ETF.
iShares Biotechnology ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares Biotechnology ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Feb 5, 2001 |
| Managers | Paul Whitehead Greg Savage Jennifer Hsui |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| GILD | Gilead Sciences Inc | 7.35% |
| REGN | Regeneron Pharmaceutic... | 6.00% |
| VRTX | Nvaesrtex Pharmaceutic... | 7.81% |
| AMGN | Amgen Inc. | 8.46% |
| ALNY | Alnylam Pharmaceutical... | 2.28% |
| AS | Argenx Se Sponsored Ad... | 3.43% |
| NTRA | Natera Inc | 2.94% |
| BIIB | Biogen Inc. | 2.39% |
| RVMD | Revolution Medicines I... | 2.88% |
| ILMN | Illumina, Inc. | 2.40% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
